Efficacy of Preoperative Enema in the Prevention of Catheter Dysfunction in Peritoneal Dialysis

February 17, 2022 updated by: Shiren sun, Air Force Military Medical University, China

Efficacy and Safety of Preoperative Enema in the Prevention of Catheter Dysfunction in Peritoneal Dialysis: A RCT Study

A prospective, randomized, controlled study was conducted to identify patients with end-stage renal disease who required open peritoneal dialysis catheterization, preoperative enema or no enema was used to evaluate the efficacy and safety of reducing catheter dysfunction.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

A prospective, randomized, controlled study was conducted to identify patients with end-stage renal disease who required open peritoneal dialysis catheterization, preoperative enema or no enema was used to evaluate the efficacy and safety of reducing catheter dysfunction. All the patients were divided into two groups: preoperative enema group and no intervention group. The peritoneal dialysis malfuction were observed.

Study Type

Interventional

Enrollment (Anticipated)

136

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age ≥18;
  • Maintenance peritoneal dialysis treatment is required for end-stage Renal Disease;
  • First-time open surgeon peritoneal dialysis catheterization patient;
  • Only straight double-cuff Tenckhoff dialysis catheters were used.
  • Willing to participate in this study and sign informed consent form.

Exclusion Criteria:

  • peritoneal dialysis contraindication;
  • Enema contraindication;
  • Patients refuse enema;
  • Expected survival time < 3 months;
  • Catharsis such as Senna Leaf and lactulose used before operation or colonic dialysis and enema used 3 days before operation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Enema group
preoperative enema

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of Catheter dysfunction requiring intervention within 3 months of peritoneal dialysis catheterization
Time Frame: 3 months
3 months
Time of first peritoneal dialysis catheter dysfunction
Time Frame: 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Incidence of Catheter dysfunction requiring intervention within 6 months of peritoneal dialysis catheterization
Time Frame: 6 months
6 months
Catheter survival time
Time Frame: 6 months
6 months
Incidence of peritoneal dialysis-associated Peritonitis
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

February 1, 2022

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

December 1, 2024

Study Registration Dates

First Submitted

February 9, 2022

First Submitted That Met QC Criteria

February 17, 2022

First Posted (Actual)

February 28, 2022

Study Record Updates

Last Update Posted (Actual)

February 28, 2022

Last Update Submitted That Met QC Criteria

February 17, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • enema for PD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Peritoneal Dialysis Access Failure

Clinical Trials on enema

Subscribe